Inventor · disambiguated record
Jeff Davis
Also filed as: DAVIS JEFF
8 granted patents·3 pending applications·10 citations·filing 2019–2024
82Inventor score
Files withFORMA THERAPEUTICS INC11
Top patents by PatentIndex Score
11 records- 0195US11497743B2Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutationFORMA THERAPEUTICS INC·Filed 2020·Granted Nov 15, 2022·3 cites·22 claims
- 0291US11963956B2Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·1 cites·20 claims
- 0388US11738018B2Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2021·Granted Aug 29, 2023·1 cites·20 claims
- 0484US11311527B2Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2020·Granted Apr 26, 2022·1 cites·19 claims
- 0584US11013734B2Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutationFORMA THERAPEUTICS INC·Filed 2019·Granted May 25, 2021·1 cites·24 claims
- 0682US11576906B2Inhibiting mutant IDH-1FORMA THERAPEUTICS INC·Filed 2019·Granted Feb 14, 2023·1 cites·3 claims
- 0780US2024148718A1INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0878US11013733B2Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1)FORMA THERAPEUTICS INC·Filed 2019·Granted May 25, 2021·1 cites·21 claims
- 0977US2025082628A1INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1076US11376246B2Inhibiting mutant IDH-1FORMA THERAPEUTICS INC·Filed 2019·Granted Jul 5, 2022·1 cites·10 claims
- 1161US2023101121A1Treating patients harboring an isocitrate dehydrogenase-1 (idh-1) mutationFORMA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeff Davis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →